Melexis NV

ENXTBR:MELE Voorraadrapport

Marktkapitalisatie: €2.6b

Melexis Toekomstige groei

Future criteriumcontroles 4/6

Melexis zal naar verwachting groeien in winst en omzet met respectievelijk 19.2% en 8.7% per jaar. De winst per aandeel zal naar verwachting groeien met 19.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 40.1% zijn.

Belangrijke informatie

19.2%

Groei van de winst

19.20%

Groei van de winst per aandeel

Semiconductor winstgroei24.6%
Inkomstengroei8.7%
Toekomstig rendement op eigen vermogen40.09%
Dekking van analisten

Good

Laatst bijgewerkt18 Aug 2026

Recente toekomstige groei-updates

Analyse-artikel Feb 08

Melexis NV (EBR:MELE) Yearly Results: Here's What Analysts Are Forecasting For This Year

It's been a sad week for Melexis NV ( EBR:MELE ), who've watched their investment drop 16% to €53.25 in the week since...
Analyse-artikel Aug 02

Melexis NV Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

A week ago, Melexis NV ( EBR:MELE ) came out with a strong set of half-yearly numbers that could potentially lead to a...

Recent updates

Narratiefupdate Aug 09

MELE: Future Returns Will Rely On Higher P/E Despite Softer Outlook

Analysts have raised their fair value estimate for Melexis from €52 to €56 as part of a broader recalibration of price targets, citing updated assumptions on discount rates, growth expectations and valuation multiples following recent sector commentary. What's in the News for Melexis No recent Melexis specific news items were available from the provided sources as of 6 Aug 2026.
Analyse-artikel Aug 05

Investors Can Find Comfort In Melexis' (EBR:MELE) Earnings Quality

Shareholders appeared unconcerned with Melexis NV's ( EBR:MELE ) lackluster earnings report last week. We did some...
Narratiefupdate Jul 26

MELE: Higher 75 Price Level Will Test Earnings And Margin Conviction

The latest Narrative Update on Melexis reflects a higher analyst price target of €75, up from €71.92, as analysts factor in a slightly richer assumed future P/E and profit margin, along with Street research that has lifted formal targets while becoming more neutral on the stock overall. Analyst Commentary Recent Street research on Melexis paints a mixed picture, with a higher cluster of price targets around €75 but a more cautious stance on rating, as some analysts balance potential growth in semiconductor demand against concerns tied to broader tech hardware and AI sentiment.
Narratiefupdate Jul 12

MELE: Street Repricing And 2026 Outlook Will Support Further Upside Potential

The analyst fair value estimate for Melexis has been raised from €92 to €96, reflecting updated assumptions on growth, margins and discount rates, along with recent Street research where multiple firms lifted their price targets even as one shifted its rating to Hold. Analyst Commentary Recent Street research on Melexis presents a mixed backdrop, with some caution around the broader tech hardware sector alongside higher fair value and price targets.
Analyse-artikel Feb 08

Melexis NV (EBR:MELE) Yearly Results: Here's What Analysts Are Forecasting For This Year

It's been a sad week for Melexis NV ( EBR:MELE ), who've watched their investment drop 16% to €53.25 in the week since...
Analyse-artikel Feb 07

Melexis (EBR:MELE) Has Affirmed Its Dividend Of €1.68

Melexis NV ( EBR:MELE ) has announced that it will pay a dividend of €1.68 per share on the 21st of May. This makes the...
Analyse-artikel Jan 03

Melexis NV's (EBR:MELE) P/E Still Appears To Be Reasonable

With a price-to-earnings (or "P/E") ratio of 21.7x Melexis NV ( EBR:MELE ) may be sending bearish signals at the...
Analyse-artikel Nov 28

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyse-artikel Nov 15

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Key Insights The projected fair value for Melexis is €54.64 based on 2 Stage Free Cash Flow to Equity With €55.65 share...
Analyse-artikel Oct 23

Returns On Capital At Melexis (EBR:MELE) Have Stalled

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
Analyse-artikel Oct 09

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Melexis NV's ( EBR:MELE ) investors are due to receive a payment of €0.91 per share on 16th of October. This means the...
Analyse-artikel Sep 11

At €66.95, Is It Time To Put Melexis NV (EBR:MELE) On Your Watch List?

While Melexis NV ( EBR:MELE ) might not have the largest market cap around , it saw a decent share price growth of 14...
Analyse-artikel Aug 02

Melexis NV Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

A week ago, Melexis NV ( EBR:MELE ) came out with a strong set of half-yearly numbers that could potentially lead to a...
Analyse-artikel Jul 09

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Analyse-artikel Jun 26

Is Melexis (EBR:MELE) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyse-artikel May 13

Earnings Not Telling The Story For Melexis NV (EBR:MELE) After Shares Rise 32%

Melexis NV ( EBR:MELE ) shareholders would be excited to see that the share price has had a great month, posting a 32...
Analyse-artikel May 07

Shareholders May Be Wary Of Increasing Melexis NV's (EBR:MELE) CEO Compensation Package

Key Insights Melexis to hold its Annual General Meeting on 13th of May Total pay for CEO Marc Biron includes €385.0k...
Analyse-artikel May 04

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €1.68

The board of Melexis NV ( EBR:MELE ) has announced that it will pay a dividend of €1.68 per share on the 22nd of May...
Analyse-artikel Apr 06

Under The Bonnet, Melexis' (EBR:MELE) Returns Look Impressive

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Analyse-artikel Mar 23

Melexis NV's (EBR:MELE) Shares May Have Run Too Fast Too Soon

There wouldn't be many who think Melexis NV's ( EBR:MELE ) price-to-earnings (or "P/E") ratio of 13.2x is worth a...
Analyse-artikel Mar 09

At €58.75, Is It Time To Put Melexis NV (EBR:MELE) On Your Watch List?

Melexis NV ( EBR:MELE ), is not the largest company out there, but it saw significant share price movement during...
Analyse-artikel Feb 08

Melexis NV Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Shareholders might have noticed that Melexis NV ( EBR:MELE ) filed its annual result this time last week. The early...
Analyse-artikel Feb 04

Is Melexis (EBR:MELE) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analyse-artikel Jan 08

Is Melexis NV (EBR:MELE) Trading At A 44% Discount?

Key Insights Melexis' estimated fair value is €104 based on 2 Stage Free Cash Flow to Equity Current share price of...
Analyse-artikel Dec 26

Melexis (EBR:MELE) Knows How To Allocate Capital Effectively

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analyse-artikel Nov 29

Improved Earnings Required Before Melexis NV (EBR:MELE) Shares Find Their Feet

With a price-to-earnings (or "P/E") ratio of 11.3x Melexis NV ( EBR:MELE ) may be sending bullish signals at the...
Analyse-artikel Oct 31

These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analyse-artikel Oct 11

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

The board of Melexis NV ( EBR:MELE ) has announced that it will pay a dividend of €0.91 per share on the 17th of...
Analyse-artikel Oct 01

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Melexis NV ( EBR:MELE ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Analyse-artikel Aug 31

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Melexis NV's ( EBR:MELE ) healthy profit numbers didn't contain any surprises for investors. We think this is due to...
Analyse-artikel Aug 19

There's Reason For Concern Over Melexis NV's (EBR:MELE) Price

With a median price-to-earnings (or "P/E") ratio of close to 16x in Belgium, you could be forgiven for feeling...
Analyse-artikel Aug 02

Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Melexis NV ( EBR:MELE ) last week reported its latest quarterly results, which makes it a good time for investors to...
Analyse-artikel Jul 04

A Look At The Fair Value Of Melexis NV (EBR:MELE)

Key Insights Melexis' estimated fair value is €83.32 based on 2 Stage Free Cash Flow to Equity With €82.70 share price...
Analyse-artikel Jun 20

Is There Now An Opportunity In Melexis NV (EBR:MELE)?

Melexis NV ( EBR:MELE ), is not the largest company out there, but it saw a decent share price growth of 19% on the...
Analyse-artikel Jun 07

Melexis (EBR:MELE) Knows How To Allocate Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analyse-artikel May 22

Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analyse-artikel May 08

Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

Key Insights Melexis' Annual General Meeting to take place on 14th of May Total pay for CEO Marc Biron includes €381.7k...
Analyse-artikel Mar 27

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Key Insights Melexis' estimated fair value is €81.96 based on 2 Stage Free Cash Flow to Equity With €75.45 share price...
Analyse-artikel Mar 14

At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Melexis NV ( EBR:MELE ), is not the largest company out there, but it received a lot of attention from a substantial...
Analyse-artikel Feb 28

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
Analyse-artikel Feb 15

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

The recent earnings posted by Melexis NV ( EBR:MELE ) were solid, but the stock didn't move as much as we expected. We...
Analyse-artikel Jan 02

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyse-artikel Dec 09

What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Melexis NV ( EBR:MELE ), is not the largest company out there, but it led the ENXTBR gainers with a relatively large...
Analyse-artikel Nov 27

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analyse-artikel Nov 15

Melexis (EBR:MELE) Knows How To Allocate Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analyse-artikel Nov 03

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Key Insights Melexis' estimated fair value is €88.88 based on 2 Stage Free Cash Flow to Equity With €72.30 share price...

Winst- en omzetgroeiprognoses

ENXTBR:MELE - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20281,04219120228812
12/31/202795315816225413
12/31/202686912221426812
6/30/2026849104204239N/A
3/31/2026843111166199N/A
12/31/202584011397126N/A
9/30/202582310893126N/A
6/30/202585513295134N/A
3/31/2025889143127169N/A
12/31/2024933171120173N/A
9/30/2024986203101169N/A
6/30/202498720967150N/A
3/31/2024978211-913N/A
12/31/2023964209-923N/A
9/30/2023938212-747N/A
6/30/2023909204-2142N/A
3/31/2023881199132184N/A
12/31/2022836197148188N/A
9/30/2022779178158194N/A
6/30/2022722166124161N/A
3/31/2022672152105140N/A
12/31/2021644131103142N/A
9/30/202162512295132N/A
6/30/202158410092123N/A
3/31/20215257680109N/A
12/31/2020508697196N/A
9/30/2020487617295N/A
6/30/20204896181104N/A
3/31/202050967N/A101N/A
12/31/201948760N/A94N/A
9/30/201950173N/A105N/A
6/30/201952588N/A96N/A
3/31/2019547101N/A98N/A
12/31/2018569115N/A100N/A
9/30/2018560114N/A78N/A
6/30/2018541112N/A89N/A
3/31/2018527114N/A106N/A
12/31/2017512111N/A113N/A
9/30/2017499109N/A116N/A
6/30/2017486107N/A96N/A
3/31/201747099N/A108N/A
12/31/201645696N/A108N/A
9/30/201643993N/A116N/A
6/30/201642693N/A134N/A
3/31/201641595N/A127N/A
12/31/201540099N/A115N/A
9/30/201538697N/A109N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei MELE ( 19.2% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van MELE ( 19.2% per jaar) zal naar verwachting sneller groeien dan de Belgian markt ( 11.9% per jaar).

Hoge groeiwinsten: De winst van MELE zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van MELE ( 8.7% per jaar) zal naar verwachting sneller groeien dan de markt Belgian ( 7.3% per jaar).

Hoge groei-inkomsten: De omzet van MELE ( 8.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen MELE zal naar verwachting over 3 jaar zeer hoog zijn ( 40.1 %).


Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/08/19 22:11
Aandelenkoers aan het einde van de dag2026/08/19 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Melexis NV wordt gevolgd door 19 analisten. 13 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Tammy QiuBerenberg
Trion ReidBerenberg
Anna PatriceBerenberg